M Kirk
Overview
Explore the profile of M Kirk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
164
Citations
2139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jessup R, Bramston C, Beauchamp A, Gust A, Cvetanovska N, Cao Y, et al.
BMJ Open
. 2023 Mar;
11(12):e049222.
PMID: 36927862
Objectives: The COVID-19 pandemic has changed the way people are accessing healthcare. The aim of this study was to examine the impact of COVID-19 on emergency department (ED) attendance for...
2.
McLure A, Clements A, Kirk M, Glass K
Epidemiol Infect
. 2019 May;
147:e152.
PMID: 31063089
Clostridium difficile infections (CDIs) affect patients in hospitals and in the community, but the relative importance of transmission in each setting is unknown. We developed a mathematical model of C....
3.
McLure A, Furuya-Kanamori L, Clements A, Kirk M, Glass K
J Hosp Infect
. 2019 Mar;
102(2):157-164.
PMID: 30880267
Background: Clostridium difficile infection (CDI) is the leading cause of antibiotic-associated diarrhoea with peak incidence in late winter or early autumn. Although CDI is commonly associated with hospitals, community transmission...
4.
McLure A, Clements A, Kirk M, Glass K
J Hosp Infect
. 2017 Dec;
99(4):453-460.
PMID: 29258917
Background: Clostridium difficile infections occur frequently among hospitalized patients, with some infections acquired in hospital and others in the community. International guidelines classify cases as hospital-acquired if symptom onset occurs...
5.
Zou J, Yin L, Shen J, Corradetti M, Kirk M, Rengan R, et al.
Med Phys
. 2017 May;
39(6Part3):3611.
PMID: 28517420
Purpose: RapidArc is routinely used for stereotactic radiotherapy for lung cancer. While treatment dose is optimized and calculated on a static CT image, the motion of the target in conjunction...
6.
Chen Y, Ford L, Hall G, Dobbins T, Kirk M
Epidemiol Infect
. 2015 Jun;
144(2):241-6.
PMID: 26095130
The aim of this study was to estimate the healthcare usage and loss of productivity due to gastroenteritis in Australia using the National Gastroenteritis Survey II. In 2008-2009, 7578 participants...
7.
Krause G, Kirk M, Heber U, Osmond C
Planta
. 2014 Jan;
142(2):229-33.
PMID: 24408108
When isolated intact chloroplasts or cells from spinach (Spinacia oleracea L.) leaves are incubated in the light in the absence of CO2, their capacity for subsequent CO2-dependent photosynthetic oxygen evolution...
8.
Matheson C, Jaffray M, Ryan M, Bond C, Fraser K, Kirk M, et al.
Int J Drug Policy
. 2013 Dec;
25(3):407-15.
PMID: 24332456
Background: Research evidence is strong for opiate replacement treatment (ORT). However, public opinion (attitudes) can be at odds with evidence. This study explored the relationships between, attitudes, knowledge of drugs...
9.
Andrews T, Whittle B, Field M, Balakishnan B, Zhang Y, Shao Y, et al.
Open Biol
. 2012 Jun;
2(5):120061.
PMID: 22724066
Accurate identification of sparse heterozygous single-nucleotide variants (SNVs) is a critical challenge for identifying the causative mutations in mouse genetic screens, human genetic diseases and cancer. When seeking to identify...
10.
Affolder T, Akimoto H, Akopian A, Albrow M, Amaral P, Amendolia S, et al.
Phys Rev Lett
. 2011 Sep;
84(8):1663-8.
PMID: 21923205
We have studied the production of B hadrons in 1.8-TeV pp[over ¯] collisions. We present measurements of the fragmentation fractions, f_{u}, f_{d}, f_{s}, and f_{baryon}, of produced b quarks that...